All Phenotypes Rassf5<tm1Kina> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Rassf5^tm1Kina/Rassf5^tm1Kina	B6.Cg-Rassf5^tm1Kina	MGI:4939894
hm2	Rassf5^tm1Kina/Rassf5^tm1Kina	involves: C57BL/6 * CBA * ICR	MGI:3054901
ht3	Rassf5^tm1Kina/Rassf5⁺	involves: C57BL/6 * CBA * ICR	MGI:3054902
cx4	Cdkn1b^tm2Kin/Cdkn1b^tm2Kin Rassf5^tm1Kina/Rassf5^tm1Kina	involves: C57BL/6 * CBA	MGI:4939905

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

enlarged spleen ( J:168749 )

increased B cell number ( J:168749 )

• total B and T cells are increased by about 50%

increased plasma cell number ( J:168749 )

• CD138+B220+ plasma cells are increased in 10 month old female mutants

increased T cell number ( J:168749 )

• total B and T cells are increased by about 50%

increased memory T cell number ( J:168749 )

• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants

abnormal lymphocyte physiology ( J:168749 )

• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation

increased B cell proliferation ( J:168749 )

• primary B cells exhibit accelearated S phase entry after stimulation

increased T cell proliferation ( J:168749 )

• primary T cells exhibit accelerated S phase entry after stimulation

increased IgG level ( J:168749 )

• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice

• deposits of IgG and C3 in the kidney

enlarged lymph nodes ( J:168749 )

increased anti-double stranded DNA antibody level ( J:168749 )

• aged mice exhibit high titers of antibodies to dsDNA

glomerulonephritis ( J:168749 )

• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months

neoplasm

increased hepatocellular carcinoma incidence ( J:168749 )

• mutants develop hepatocellular carcinomas after 1.5 years of age

increased B cell derived lymphoma incidence ( J:168749 )

• mutants develop B220+CD19+ diffuse large B cell lymphomas

• about 30% of mutants develop B cell lymphomas in peripheral lymph nodes and spleen at 1 year of age

• lymphomas are IgM+, IgD+, CD21+, CD23+, and mature B cell type; progressed lymphomas often lose these markers

• lymphomas are monoclonal or oligoclonal in origin

• B cell lymphomas are not related to severity of autoimmune phenotypes

increased lung adenocarcinoma incidence ( J:168749 )

• mutants develop lung adenocarcinomas after 1.5 years of age

hematopoietic system

enlarged spleen ( J:168749 )

increased B cell number ( J:168749 )

• total B and T cells are increased by about 50%

increased plasma cell number ( J:168749 )

• CD138+B220+ plasma cells are increased in 10 month old female mutants

increased T cell number ( J:168749 )

• total B and T cells are increased by about 50%

increased memory T cell number ( J:168749 )

• CD44+CD62L- effector-memory T cells are increased in 10 month old female mutants

abnormal lymphocyte physiology ( J:168749 )

• lymphocyte hyperproliferation, with lymphocytes exhibiting enhanced S phase entry after stimulation

increased B cell proliferation ( J:168749 )

• primary B cells exhibit accelearated S phase entry after stimulation

increased T cell proliferation ( J:168749 )

• primary T cells exhibit accelerated S phase entry after stimulation

increased IgG level ( J:168749 )

• aged mice exhibit a 2-fold increase in serum IgG compared to wild-type mice

• deposits of IgG and C3 in the kidney

homeostasis/metabolism

increased urine protein level ( J:168749 )

renal/urinary system

increased urine protein level ( J:168749 )

glomerulonephritis ( J:168749 )

• females exhibit evidence of glomerulonephritis by 10 months of age while males show similar phenotypes at a later age of 15-18 months

liver/biliary system

increased hepatocellular carcinoma incidence ( J:168749 )

• mutants develop hepatocellular carcinomas after 1.5 years of age

cellular

increased B cell proliferation ( J:168749 )

• primary B cells exhibit accelearated S phase entry after stimulation

increased T cell proliferation ( J:168749 )

• primary T cells exhibit accelerated S phase entry after stimulation

growth/size/body

enlarged spleen ( J:168749 )

respiratory system

increased lung adenocarcinoma incidence ( J:168749 )

• mutants develop lung adenocarcinomas after 1.5 years of age

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
systemic lupus erythematosus		DOID:9074	OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420	J:168749

Allelic Composition	Rassf5^tm1Kina/Rassf5^tm1Kina
Genetic Background	involves: C57BL/6 * CBA * ICR

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rassf5^tm1Kina mutation (0 available); any Rassf5 mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

abnormal leukocyte migration ( J:92670 )

• defective chemokine-triggered lymphocyte adhesion and migration

abnormal thymus cell ratio ( J:92670 )

• decrease in double positive CD4+ CD8+ cells

• increase in single positive CD4+ and CD8+ cells

• cellular migration out of thymus is 10% of wildtype

abnormal thymus corticomedullary boundary morphology ( J:92670 )

• boundary of cortex and medulla ambiguous

abnormal thymus medulla morphology ( J:92670 )

• spotty appearance of medulla

decreased thymocyte number ( J:92670 )

• total thymocyte numbers decreased 50-60% in 7-9 week old mice

abnormal B cell differentiation ( J:92670 )

• impairment of B cell maturation

• defective trafficking of B cells into spleen

• increased number of immature B cells in blood

abnormal spleen red pulp morphology ( J:92670 )

• reciprocal increase in T and B cells in splenic red pulp

spleen hypoplasia ( J:92670 )

immune system

abnormal leukocyte migration ( J:92670 )

• defective chemokine-triggered lymphocyte adhesion and migration

abnormal thymus cell ratio ( J:92670 )

• decrease in double positive CD4+ CD8+ cells

• increase in single positive CD4+ and CD8+ cells

• cellular migration out of thymus is 10% of wildtype

abnormal thymus corticomedullary boundary morphology ( J:92670 )

• boundary of cortex and medulla ambiguous

abnormal thymus medulla morphology ( J:92670 )

• spotty appearance of medulla

decreased thymocyte number ( J:92670 )

• total thymocyte numbers decreased 50-60% in 7-9 week old mice

abnormal B cell differentiation ( J:92670 )

• impairment of B cell maturation

• defective trafficking of B cells into spleen

• increased number of immature B cells in blood

abnormal spleen red pulp morphology ( J:92670 )

• reciprocal increase in T and B cells in splenic red pulp

spleen hypoplasia ( J:92670 )

abnormal lymph node cell ratio ( J:92670 )

• total lymphocyte numbers in peripheral lymph nodes are decreased to one half of wild-type

abnormal lymph node cortex morphology ( J:92670 )

• decrease in size and cellular density of B cell follicles and T cell zones

abnormal dendritic cell physiology ( J:92670 )

• reduced numbers of CD11c+ (Itgax) dendritic cells in spleen

• following activation, dermal and splenic dendritic cells fail to migrate to draining lymph nodes and white pulp

cellular

abnormal leukocyte migration ( J:92670 )

• defective chemokine-triggered lymphocyte adhesion and migration

endocrine/exocrine glands

abnormal thymus cell ratio ( J:92670 )

• decrease in double positive CD4+ CD8+ cells

• increase in single positive CD4+ and CD8+ cells

• cellular migration out of thymus is 10% of wildtype

abnormal thymus corticomedullary boundary morphology ( J:92670 )

• boundary of cortex and medulla ambiguous

abnormal thymus medulla morphology ( J:92670 )

• spotty appearance of medulla

decreased thymocyte number ( J:92670 )

• total thymocyte numbers decreased 50-60% in 7-9 week old mice

Allelic Composition	Rassf5^tm1Kina/Rassf5⁺
Genetic Background	involves: C57BL/6 * CBA * ICR

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rassf5^tm1Kina mutation (0 available); any Rassf5 mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

lymphoid hypoplasia ( J:92670 )

• total lymphocyte numbers in peripheral lymph nodes are decreased to one third of wild-type

Allelic Composition	Cdkn1b^tm2Kin/Cdkn1b^tm2Kin Rassf5^tm1Kina/Rassf5^tm1Kina
Genetic Background	involves: C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn1b^tm2Kin mutation (1 available); any Cdkn1b mutation (26 available)
Rassf5^tm1Kina mutation (0 available); any Rassf5 mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

immune system phenotype ( J:168749 )

• development of glomerulonephritis that is observed in single Rassf5 homozygotes is suppressed, in addition, CD138+B220+ plasma cells are reduced by 67%, CD44+CD62L- effector-memory T cells are reduced by 28%, and titers of antibodies to dsDNA are decreased by 58% compared to single Rassf5 homozygotes and deposition of IgG in the kidney is rarely detected compared to single Rassf5 homozygotes

homeostasis/metabolism

increased urine protein level ( J:168749 )

• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%)

renal/urinary system

increased urine protein level ( J:168749 )

• incidence of proteinuria is reduced (22%) compared to single Rassf5 homozygotes (63%)

neoplasm

neoplasm ( J:168749 )

N	• mutants do not develop B cell lymphomas or other tumors

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24